This inventor holds 7 USPTO granted patents and 7 published patent applications. Top assignee: Atossa Therapeutics, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Yao-Lin Sun: Innovator in Hormone-Dependent Treatments
Introduction
Yao-Lin Sun is a prominent inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for hormone-dependent disorders. With a total of six patents to his name, Sun's work is recognized for its industrial scalability and therapeutic potential.
Latest Patents
Among his latest patents, Sun has developed methods for making and using endoxifen. This includes industrially scalable methods for producing (Z)-endoxifen or its salts, as well as crystalline forms of endoxifen. His patents also encompass compositions that utilize these methods for treating hormone-dependent breast and reproductive tract disorders.
Career Highlights
Yao-Lin Sun is currently associated with Atossa Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on creating effective treatments that address critical health issues related to hormone dependency.
Collaborations
Sun collaborates with notable professionals in his field, including Steven C. Quay and LungHu Wang. These partnerships enhance the research and development efforts at Atossa Therapeutics, Inc.
Conclusion
Yao-Lin Sun's contributions to the field of hormone-dependent treatments through his innovative patents highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile